Manganese improves anti-PD-L1 immunotherapy via eliciting type I interferon signaling in melanoma
{{output}}
The immune checkpoint inhibitor therapy represented by blocking programmed cell death protein 1/ programmed cell death-ligand 1 (PD-1/PD-L1) has made significant progress in melanoma treatment. However, the response rate and therapeutic effect of immunotherapy... ...
